The below listed sell-side analysts currently cover ASML.
| Company | Contact | City |
|---|---|---|
| ABN AMRO - ODDO BHF | Stephane Houri | Paris |
| Bank of America | Didier Scemama | London |
| Barclays | Simon Coles | London |
| Berenberg Bank | Tammy Qiu | London |
| Bernstein | Sara Russo | London |
| Cantor | C.J. Muse | New York |
| Citigroup | Andrew Gardiner | London |
| Cowen | Krish Sankar | San Francisco |
| DeGroof Petercam | Michael Roeg | Amsterdam |
| Deutsche Bank | Rob Sanders | London |
| Evercore ISI | Mark Lipacis | New York |
| Exane BNP Paribas | David O’Connor | San Francisco |
| Goldman Sachs | Alex Duval | London |
| HSBC | Adi Metuku | London |
| ING | Marc Hesselink | Amsterdam |
| Independent Minds | Andrew Hayman | London |
| InsingerGilissen | Jos Versteeg | Amsterdam |
| Jeffries | Janardan Menon | London |
| JP Morgan | Sandeep Deshpande | London |
| KBC | Thibault Leneeuw | Brussels |
| Kepler Cheuvreux | Ruben DeVos | Brussels |
| Mizuho | Kevin Wang | Hong Kong |
| Morgan Stanley | Lee Simpson | London |
| Morningstar | Javier Correonero | Amsterdam |
| New Street research | Pierre Ferragu | New York |
| Raymond James | Srini Pajjuri | San Francisco |
| Redburn Atlantic | Timm Schulze-Melander | London |
| Santander | Carlos Treviño Peinador | Madrid |
| Stifel | Jürgen Wagner | Frankfurt |
| Susquehanna | Mehdi Hosseini | San Francisco |
| Technology Advisory Group | Warren Lau | Hong Kong |
| UBS | Francois-Xavier Bouvignies | London |
| Van Lanschot-Kempen | Nikos Kolokotronis | Amsterdam |
| Wells Fargo | Joe Quatrochi | St. Louis |
| Wolfe Research | Chris Caso | New York |
Important legal notice
ASML is followed by the sell-side analysts brokerage firms listed above. The list may not be complete and is subject to change. Please note that any opinions, estimates or forecasts regarding ASML's performance made by the analysts at these firms are theirs alone and do not represent opinions, forecasts or predictions of ASML or its management. ASML does not by listing these firms imply its endorsement of or concurrence with such information, conclusions or recommendations.